On December 19th, 2018, Mr. Heng Fai Chan, holder
Post# of 30028
(Total Views: 489)
Posted On: 12/28/2018 10:08:14 PM
On December 19th, 2018, Mr. Heng Fai Chan, holder of 250,000 Series F Preferred Shares, and Mr. Gerald Commissiong, the Company’s CEO and holder of Series B Preferred Shares, jointly signed a shareholder written consent document authorizing the increase in the number of common shares from 250,000,000 to 400,000,000. Jointly, Mr. Commissiong and Mr. Chan represented 49,999,650,001 out of a total 50,146,258,701 votes, or 99.7%.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼